Free Shipping
Buy Now, Pay Later
Eligible
Red Light Therapy for Trichomonas vaginalis: An Emerging Therapeutic Frontier

Trichomonas vaginalis infection remains the most prevalent non-viral sexually transmitted infection worldwide, with approximately 156 million new cases annually. While nitroimidazoles such as metronidazole represent the current standard of care, emerging…


















